We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Skyhawk Therapeutics

News List

Skyhawk Therapeutics, Merck Expand RNA Alliance contractpharma
May 14, 2020
Aims to discover and develop novel small molecules that modulate RNA splicing for autoimmune and metabolic diseases.
Merck and Skyhawk Therapeutics sign collaboration agreement pharmaceutical-technology
July 10, 2019
Merck has signed a strategic collaboration agreement with Skyhawk Therapeutics to use its SkySTAR technology to develop drug candidates for patients with neurodegenerative diseases and cancer.
Pair of deals boosts Biogen’s early-stage CNS pipeline pharmaphorum
January 08, 2019
Biogen has signed a brace of collaborations to expand its central nervous system (CNS) pipeline, adding new candidates for Alzheimer’s, multiple sclerosis and other neurological diseases.